HUNTINGTON INGALLS INDUSTRIES, INC. (HII) /
The debt of HUNTINGTON INGALLS INDUSTRIES, INC. over the past 10 years
Chart HUNTINGTON INGALLS INDUSTRIES, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2023, HUNTINGTON INGALLS INDUSTRIES, INC. had liquid cash of $430M and total debt of $2.44B: net debt of $2.02B. It had more debt than liquid cash at all 8 year-ends shown. Total debt was highest at the end of fiscal 2021 ($3.3B) and lowest at the end of fiscal 2016 ($1.28B). No net cash figure is on file for fiscal 2024 and 2025.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | — | $2.7B | — |
| 2024ended Dec 31, 2024 | — | $3.2B | — |
| 2023ended Dec 31, 2023 | $430M | $2.44B | -$2.02B |
| 2022ended Dec 31, 2022 | $467M | $2.9B | -$2.44B |
| 2021ended Dec 31, 2021 | $627M | $3.3B | -$2.67B |
| 2020ended Dec 31, 2020 | $512M | $1.69B | -$1.17B |
| 2019ended Dec 31, 2019 | $75M | $1.29B | -$1.21B |
| 2018ended Dec 31, 2018 | $240M | $1.28B | -$1.04B |
| 2017ended Dec 31, 2017 | $701M | $1.28B | -$578M |
| 2016ended Dec 31, 2016 | $720M | $1.28B | -$558M |
Fiscal years as HUNTINGTON INGALLS INDUSTRIES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on HUNTINGTON INGALLS INDUSTRIES, INC.
- The revenue of HUNTINGTON INGALLS INDUSTRIES, INC.
- The profitability of HUNTINGTON INGALLS INDUSTRIES, INC.
- The cash flow of HUNTINGTON INGALLS INDUSTRIES, INC.
- The dividends of HUNTINGTON INGALLS INDUSTRIES, INC.
- All of HUNTINGTON INGALLS INDUSTRIES, INC.'s financials, charted
Companies of a similar size
- KYMRKYMERA THERAPEUTICS, INC.
- FNFFIDELITY NATIONAL FINANCIAL, INC.
- DDSDILLARD’S, INC.
- SFSTIFEL FINANCIAL CORP
- ARWARROW ELECTRONICS, INC.
Not investment advice. This page shows what HUNTINGTON INGALLS INDUSTRIES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.